DAMGO, a μ‐opioid receptor selective agonist, distinguishes between μ‐ and δ‐opioid receptors around their first extracellular loops
Open Access
- 2 January 1995
- journal article
- Published by Wiley in FEBS Letters
- Vol. 357 (1), 93-97
- https://doi.org/10.1016/0014-5793(94)01341-w
Abstract
The structural basis of μ‐opioid receptor (OPR) for the specificity in its ligand binding was investigated using chimeric μ/δ‐OPRs. Replacement of the region around the first extracellular loop of δ‐OPR with the corresponding region of μ‐OPR gave the resultant chimeric receptor the similar affinity to DAMGO compared with the native μ‐OPR. The reciprocal replacement deprived the high affinity to DAMGO from μ‐OPR. These results indicate that the difference(s) in the structure around the first extracellular loop is critical for DAMGO to distinguish between μ‐ and δ‐OPRs. Furthermore, displacement studies revealed that this region is partly involved in the discrimination between μ‐ and δ‐OPRs by other peptidic μ‐selective ligands, such as dermorphin, morphiceptin and CTOP, but not by non‐peptidic ligands, such as morphine and naloxone.Keywords
This publication has 11 references indexed in Scilit:
- Molecular cloning and in situ hybridization histochemistry for rat μ-opioid receptorNeuroscience Research, 1994
- A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.Journal of Biological Chemistry, 1993
- Cloning and expression of a cDNA for the rat k‐opioid receptorFEBS Letters, 1993
- Primary structures and expression from cDNAs of rat opioid receptor δ‐and μ‐subtypesFEBS Letters, 1993
- Characterisation of a chimeric hD3/D2dopamine receptor expressed in CHO cellsFEBS Letters, 1993
- Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.Published by Elsevier BV ,1993
- Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonistNature, 1993
- Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.The EMBO Journal, 1990
- Chimeric α 2 -,β 2 -Adrenergic Receptors: Delineation of Domains Involved in Effector Coupling and Ligand Binding SpecificityScience, 1988